Date | Title | Description | |
---|---|---|---|
08 May 2024 | On P&L | The Company releases the first three months 2024 financial results presentation | Download |
25 Apr 2024 | On business and financial situation | ROVI announces agreement to manufacture pre-filled syringes | Download |
27 Feb 2024 | About Corporate Governance | The Company informs about the agreements adopted by the Board of Directors | Download |
27 Feb 2024 | On P&L | The Company releases the press release related to the full year 2023 financial results. | Download |
27 Feb 2024 | On P&L | The Company releases the full year 2023 financial results presentation. | Download |
Pages
Date | Title | Description | |
---|---|---|---|
21 Oct 2021 | Liquidity and counterparty agreements | Download | |
21 Oct 2021 | On business and financial situation | The Company informs of the delay in the decision on Risperidone ISM® by the U.S. Food and Drug Administration (“FDA”). | Download |
07 Oct 2021 | Liquidity and counterparty agreements | Download | |
04 Oct 2021 | Liquidity and counterparty agreements | Download | |
01 Sep 2021 | On business and financial situation | ROVI informs about the joint statement from Moderna and Takeda on the investigation of suspended lots of the vaccine | Download |
Pages
Date | Title | Description | |
---|---|---|---|
04 Oct 2018 | Share capital increases and reductions | Private placement capital increase addressed to institutional investors, excluding preferential subscription rights | Download |
02 Oct 2018 | Contratos de liquidez y contrapartida | Liquidity contract: transactions conducted in the third quarter of 2018 | Download |
24 Sep 2018 | Others on business performance and financial information | Updated information on business, financial position and risk factors | Download |
24 Sep 2018 | Share capital increases and reductions | Intention to raise gross proceeds by means of an offer addressed to institutional investors, excluding preferential subscription rights | Download |
26 Jul 2018 | Información sobre resultados | ROVI releases the 2018 first half results presentation | Download |